NCT01801475View on ClinicalTrials.gov

How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant Women

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Postoperative Nausea
Interventions
DRUG

Ondansetron

Pregnant \& non-pregnant women will receive either 4mg or 8mg of Ondansetron (IV) once prior to surgical procedure (open-label). Women are in the study for 8 hours. Babies of pregnant women are not given Ondansetron but are in the study for 24-48 hours.

Trial Locations (1)

94305

Lucile Packard Children's Hospital & Stanford Hospital, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER

NCT01801475 - How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant Women | Biotech Hunter | Biotech Hunter